You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exendin9

Showing 1 - 25 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post Bariatric Surgery, Gastric Bypass, Sleeve Gastrectomy Trial in San Antonio (Exendin-(9-39), Atropine)

Recruiting
  • Post Bariatric Surgery
  • +3 more
  • San Antonio, Texas
  • +1 more
Aug 5, 2022

Obesity Trial in New York (Exendin 9-39 and Sitagliptin, Placebo)

Withdrawn
  • Obesity
  • Exendin 9-39 and Sitagliptin
  • Placebo
  • New York, New York
    Mount Sinai - Morningside
Nov 14, 2022

Type 2 Diabetes, Obesity Trial in Rochester (procedure, behavioral, drug)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Obesity
  • Roux-en-Y Gastric Bypass (RYGB)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 5, 2022

Post Bariatric Hypoglycemia Trial in Stanford (Lyo avexitide, Liq avexitide)

Completed
Has Results
  • Post Bariatric Hypoglycemia
  • Lyo avexitide
  • Liq avexitide
  • Stanford, California
    Stanford University School of Medicine
Oct 19, 2020

Insulin Secretion Trial in Durham (Glucagon)

Completed
  • Insulin Secretion
  • Durham, North Carolina
    Duke Center for Living
May 12, 2021

Obesity Trial in Rochester (Saline, Exendin-9,39)

Completed
Has Results
  • Obesity
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 22, 2020

Congenital Hyperinsulinism Trial in Philadelphia (Exendin-(9-39), )

Completed
Has Results
  • Congenital Hyperinsulinism
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 12, 2020

Type 2 Diabetes Trial in New York (Exendin9)

Completed
  • Type 2 Diabetes Mellitus
  • Exendin9
  • New York, New York
    New York Obesity Research Center, Columbia University
Apr 21, 2020

Obesity, Diabetes, Roux-en-Y Gastric Bypass Trial in Rochester (Exendin-9,39, Saline)

Completed
  • Obesity
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 21, 2019

Glucose Metabolism Disorders Trial in Hellerup (Acarbose, Placebo Oral Tablet, Exendin (9-39))

Completed
  • Glucose Metabolism Disorders
  • Hellerup, Denmark
    Center for Diabetesresearch
Mar 25, 2020

Glucose Metabolism Disorders Trial in Copenhagen (GIP-A, Placebo, GLP-1 receptor antagonist Exendin[9-39])

Completed
  • Glucose Metabolism Disorders
  • GIP-A
  • +3 more
  • Copenhagen, Gentofte, Denmark
    Center for Diabetes Research
Jun 1, 2019

Gastric Cancer, Dumping Syndrome Trial in Cambridge (Exendin 9-39, Placebo)

Completed
Has Results
  • Gastric Cancer
  • Dumping Syndrome
  • Exendin 9-39
  • Placebo
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Aug 27, 2019

Acquired Hyperinsulinemic Hypoglycemia Trial in Palo Alto (Avexitide)

Recruiting
  • Acquired Hyperinsulinemic Hypoglycemia
  • Palo Alto, California
    Clinical and Translational Research Unit
Mar 31, 2022

Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

Completed
  • Bariatric Surgery
  • Placebo
  • +3 more
  • Hvidovre, Denmark
  • +1 more
Jan 31, 2022

Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)

Not yet recruiting
  • Pancreatectomy; Hyperglycemia
  • Intravenous infusion
  • Hellerup, Denmark
    Clinical Metabolic Physiology
Dec 14, 2021

Dyspepsia, Diabetes With Gastrointestinal Symptoms Trial in Rochester (Exendin 9-39, Microlipid, Placebo)

Completed
Has Results
  • Dyspepsia
  • Diabetes Mellitus With Gastrointestinal Symptoms
  • Exendin 9-39
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 30, 2019

Healthy Trial in Durham (Active Comparator: Sitagliptin, Placebo Comparator - No Sitagliptin)

Completed
Has Results
  • Healthy
  • Active Comparator: Sitagliptin
  • Placebo Comparator - No Sitagliptin
  • Durham, North Carolina
    Leslie Willis
Apr 6, 2021

Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)

Recruiting
  • Atherosclerosis
  • +2 more
  • Stockholm, Other, Sweden
    Dept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021

Type 2 Diabetes Trial in Hellerup (Sevelamer, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • Hellerup, Denmark
    Steno Diabetes Center Copenhagen, Gentofte Hospital
Oct 12, 2021

Glucose Metabolism Disorders Trial in Gentofte (Placebo Oral Tablet, Metformin, Saline)

Completed
  • Glucose Metabolism Disorders
  • Placebo Oral Tablet
  • +3 more
  • Gentofte, Copenhagen, Denmark
    Center for Diabetes Research
Jul 6, 2018

Obesity Trial in Nashville (Sitagliptin, Pegvisomant, Placebo)

Completed
Has Results
  • Obesity
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 25, 2018

Type 1 Diabetes, Insulin Sensitivity/Resistance Trial in Charlottesville (GLP-1, Insulin, Dextrose 20 % in Water)

Withdrawn
  • Type 1 Diabetes
  • Insulin Sensitivity/Resistance
  • Charlottesville, Virginia
    University of Virginia
Mar 7, 2022

Alzheimer, Mild Cognitive Impairment, Metabolic Syndrome Trial in Ramat Gan (Semaglutide, Intranasal insulin, Semaglutide )

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Ramat Gan, Israel
    Joseph Sagol Neuroscience center, Sheba Medical Center
Oct 3, 2023

Healthy Volunteers Trial in Stockholm (Remote conditioning, Exendin 9-39)

Completed
  • Healthy Volunteers
  • Remote conditioning
  • Exendin 9-39
  • Stockholm, Sweden
    Karolinska Institutet, Karolinska University Hospital
Mar 5, 2018

Quality of Life Trial in Besançon (Exenatide, Insulin)

Completed
  • Quality of Life
  • Besançon, France
    Post operative intensive care unit of the cardiac surgery depart
Mar 5, 2021